Navigation Links
Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:11/7/2011

NEW YORK, Nov. 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0681740/Implantable-Cardioverter-Defibrillators-and-Cardiac-Resynchronization-Therapy-Defibrillators---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides market landscape, competitive landscape and market trends information on the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Cardiac Resynchronisation Therapy - Defibrillators, Dual Chamber Implantable Cardioverter Defibrillators and Single Chamber Implantable Cardioverter Defibrillators.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market and the factors shaping it.

1 Table of Contents

1 Table of Contents 1

1.1 List of Tables 5

1.2 List of Figures 7

2 Executive Summary 8

2.1 The Global Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market is Forecast to Grow at a Rate of 5% Over the Period 2010–2017 8

2.2 Medtronic Dominates the Global ICD and CRT-D Market with a Share of More Than 40% 9

2.3 Increasing Patient Pool and Better Adoption Rates of ICD and CRT-D for Treatment of Cardiac Arrhythmias and Heart Failures to Drive Market Growth 9

2.4 The US is the Largest Market for ICD and CRT-D Devices Contributing about 56% of the Global Revenue in 2010 10

3 Introduction 11

3.1 GlobalData Report Guidance 11

4 Disease Overview - Arrhythmia 12

4.1 Types of Arrhythmia 12

4.2 Symptoms 13

5 Device Overview 14

5.1 Implantable Cardioverter Defibrillator (ICD) 14

5.1.1 Dual Chamber Implantable Cardioverter Defibrillator 14

5.1.2 Single Chamber Implantable Cardioverter Defibrillator 14

5.2 Cardio Resynchronization Therapy Defibrillators 14

6 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Market Characterization 15

6.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Historic, 2003-2010 15

6.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Forecast, 2010-2017 16

6.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Technology Trends 17

6.3.1 Percutaneous Implantable ICDs 17

6.3.2 Subcutaneous ICDs 17

6.3.3 Automatic Diagnosis 17

6.4 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Market Dynamics 17

6.4.1 Market Drivers 17

6.4.2 Market Restraints 22

7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, by Country, Revenue, 2003 - 2017 24

7.1 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Historic, 2003-2010 24

7.2 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Forecast, 2010-2017 25

7.3 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Historic, 2003 - 2010 26

7.4 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Forecast, 2010 - 2017 27

7.5 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Historic, 2003 - 2010 28

7.6 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Forecast, 2010 - 2017 29

7.7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Historic, 2003 - 2010 30

7.8 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Forecast, 2010 - 2017 31

7.9 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Historic, 2003 - 2010 32

7.10 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Forecast, 2010 - 2017 33

7.11 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Historic, 2003 - 2010 34

7.12 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Forecast, 2010-2017 35

7.13 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Historic, 2003 - 2010 36

7.14 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Forecast, 2010 - 2017 37

7.15 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Historic, 2003 - 2010 38

7.16 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Forecast, 2010 - 2017 39

7.17 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Historic, 2003 - 2010 40

7.18 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Forecast, 2010-2017 41

7.19 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Historic, 2003 - 2010 42

7.20 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Forecast, 2010 - 2017 43

7.21 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Historic, 2003 - 2010 44

7.22 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Forecast, 2010 - 2017 45

7.23 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Brazil, Revenue ($m), Historic, 2003 - 2010 46

7.24 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), Forecast, 2010 - 2017 47

8 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market - Strategic Competitive Assessment 48

8.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Global, Company Share (%), 2010 48

8.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Opportunities and Threats 49

8.2.1 Opportunities 49

8.2.2 Threats 49

8.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Market Participants 50

8.3.1 Medtronic, Inc 50

8.3.2 St Jude Medical, Inc 51

8.3.3 Boston Scientific Corporation 52

8.3.4 Biotronik 53

8.3.5 Sorin Group 54

9 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Key Marketed Products 55

9.1 Protecta XT DR/VR and Protecta DR/VR ICDs 55

9.1.1 Product Description 55

9.1.2 Features and Benefits 55

9.2 Secura DR/VR ICDs 55

9.2.1 Product Description 55

9.2.2 Features and Benefits 55

9.3 Protecta XT and Protecta CRT-Ds 55

9.3.1 Product Description 55

9.3.2 Features and Benefits 55

9.4 Consulta CRT-Ds 56

9.4.1 Product Description 56

9.4.2 Features and Benefits 56

9.5 Maximo II CRT-Ds 56

9.5.1 Product Description 56

9.6 AnalyST Accel ICDs 56

9.6.1 Product Description 56

9.6.2 Features and Benefits 56

9.7 Atlas and Atlas II ICDs 57

9.7.1 Product Description 57

9.7.2 Features and Benefits 57

9.8 Current Accel DR/VR ICDs 57

9.8.1 Product Description 57

9.8.2 Features and Benefits 57

9.9 Current RF ICDs 57

9.9.1 Product Description 57

9.9.2 Features and Benefits 57

9.10 Epic and Epic II ICDs 58

9.10.1 Product Description 58

9.10.2 Features and Benefits 58

9.11 Epic HF CRT-Ds 58

9.11.1 Product Description 58

9.11.2 Features and Benefits 58

9.12 Fortify and Fortify ST ICDs 58

9.12.1 Product Description 58

9.12.2 Features and Benefits 58

9.13 PROMOTE CRT-Ds 59

9.13.1 Product Description 59

9.13.2 Features and Benefits 59

9.14 TELIGEN ICDs 59

9.14.1 Product Description 59

9.14.2 Features and Benefits 59

9.15 CONFIENT ICDs 60

9.15.1 Product Description 60

9.15.2 Features and Benefits 60

9.16 VITALITY ICDs 60

9.16.1 Product Description 60

9.17 COGNIS CRT-Ds 60

9.17.1 Product Description 60

9.17.2 Features and Benefits 60

9.18 CONTAK RENEWAL Series CRT-Ds 61

9.18.1 Product Description 61

9.18.2 Features and Benefits 61

9.19 LIVIAN CRT-Ds 61

9.19.1 Product Description 61

9.19.2 Features and Benefits 61

9.20 Lumax 540 series ICDs and CRT-Ds 62

9.20.1 Product Description 62

9.20.2 Features and Benefits 62

9.21 Lumax 300/340 VR-T (XL)/DR-T ICD and CRT-Ds 62

9.21.1 Product Description 62

9.21.2 Features and Benefits 62

9.22 Ovatio CRT-D 62

9.22.1 Product Description 62

9.22.2 Features and Benefits 62

9.23 Paradym Family of ICDs 63

9.23.1 Product Description 63

9.23.2 Features and Benefits 63

9.24 Paradym CRT-D 63

9.24.1 Product Description 63

9.24.2 Features and Benefits 63

10 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Pipeline Assessment 64

10.1 Implantable Cardioverter Defibrillators, Pipeline Products 64

10.1.1 AnalyST ACCEL ICD 65

10.1.2 AnalyST ICD 65

10.1.3 CardiaLen ICD 66

10.1.4 Chronicle ICD 66

10.1.5 Current Plus ICD 68

10.1.6 ENERGEN ICD 69

10.1.7 FORTIFY ST ICD 69

10.1.8 INCEPTA ICD 70

10.1.9 Paradym DR ICD 70

10.1.10 Paradym VR Model 8250 ICD 71

10.1.11 PUNCTUA ICD 71

10.1.12 S-ICD 72

10.1.13 Unconditional MRI Compatible ICD 73

10.2 Cardiac Resynchronization Therapy-Defibrillators, Pipeline Products 74

10.2.1 ENERGEN CRT-D 75

10.2.2 INCEPTA CRT-D 75

10.2.3 Next Generation Quad Polar CRT- D 76

10.2.4 Paradym RF 8770 SonR CRT-D 76

10.2.5 Clinical Trials 77

10.2.6 Paradym RF CRT-D 77

10.2.7 Platinium ICD - CRT-D 78

10.2.8 Promote Quadra CRT- D 78

10.2.9 PUNCTUA CRT-D 80

10.2.10 Unify Quadra CRT-D 80

11 Implantable Cardioverter Defibrillators and CardiacResynchronization Therapy Defibrillator Market - Deals Landscape 81

11.1 Boston Scientific Corporation Completes Acquisition of Atritech 81

11.2 Boston Scientific Corporation Enters into an Agreement with Fukuda Denshi 81

11.3 St. Jude Medical Enters into an Agreement with iRhythm Technologies 82

11.4 CLT Forms Joint Venture Company with Erasmus 82

11.5 AorTech International Expands Licensing Agreement with St. Jude Medical 82

12 Appendix 83

12.1 Definitions 84

12.1.1 Cardiac Resynchronization Therapy - Defibrillator 84

12.1.2 Implantable Cardioverter Defibrillator 84

12.1.3 Dual Chamber Implantable Cardioverter Defibrillator 84

12.1.4 Single Chamber Implantable Cardioverter Defibrillator 84

12.2 Acronyms 84

12.3 Research Methodology 86

12.4 Secondary Research 87

12.5 Primary Research 87

12.6 Models 87

12.7 Forecasts 88

12.8 Expert Panels 88

12.9 GlobalData Consulting 88

12.10 Contact Us 88

12.11 Disclaimer 88

12.12 Sources 89

List of Tables

Table 1: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), 2003-2010 15

Table 2: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), 2010-2017 16

Table 3: Technological Innovations, Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators 18

Table 4: Landmark Clinical Trials for Implantable Cardioverter Defibrillators 19

Table 5: Landmark Clinical Trials for Cardiac Resynchronization Therapy-Defibrillators 20

Table 6: Cardiac Rhythm Management Market, List of Device Recalls, 2004-2010 22

Table 7: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2003-2010 24

Table 8: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2010-2017 25

Table 9: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), 2003-2010 26

Table 10: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), 2010-2017 27

Table 11: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2003-2010 28

Table 12: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2010-2017 29

Table 13: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2003-2010 30

Table 14: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2010-2017 31

Table 15: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2003-2010 32

Table 16: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2010-2017 33

Table 17: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2003-2010 34

Table 18: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2010-2017 35

Table 19: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2003-2010 36

Table 20: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2010-2017 37

Table 21: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2003-2010 38

Table 22: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2010-2017 39

Table 23: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2003-2010 40

Table 24: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2010-2017 41

Table 25: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2003-2010 42

Table 26: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2010-2017 43

Table 27: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2003-2010 44

Table 28: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2010-2017 45

Table 29: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), 2003-2010 46

Table 30: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), 2010-2017 47

Table 31: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Company Share (%), 2010 48

Table 32: Protecta XT DR/VR and Protecta DR/VR, Features and Benefits 55

Table 33: Secura DR/VR; Features and Benefits 55

Table 34: Protecta XT and Protecta CRT-Ds, Features and Benefits 55

Table 35: Consulta CRT-D; Features and Benefits 56

Table 36: Maximo II CRT-D, Features and Benefits 56

Table 37: AnalyST Accel ICD; Features and Benefits 56

Table 38: Atlas ICDs; Features and Benefits 57

Table 39: Current Accel DR/VR ICD; Features and Benefits 57

Table 40: Current RF ICD; Features and Benefits 57

Table 41: Epic ICDs; Features and Benefits 58

Table 42: Epic HF CRT-Ds, Features and Benefits 58

Table 43:Fortify and Fortify ST ICD; Features and Benefits 58

Table 44: PROMOTE CRT-Ds; Features and Benefits 59

Table 45: TELIGEN ICDs; Features and Benefits 59

Table 46: CONFIENT ICDs; Features and Benefits 60

Table 47: VITALITY ICDs; Features and Benefits 60

Table 48: COGNIS CRT-Ds, Features and Benefits 60

Table 49: CONTAK RENEWAL Series CRT-Ds, Features and Benefits 61

Table 50: LIVIAN CRT-Ds, Features and Benefits 61

Table 51: Lumax 540 series ICDs and CRT-Ds, Features and Benefits 62

Table 52: Lumax 300/340 VR-T (XL)/DR-T ICD, Features and Benefits 62

Table 53: Ovatio CRT-D, Features and Benefits 62

Table 54: Paradym Family of ICDs, Features and Benefits 63

Table 55: Paradym CRT-D, Features and Benefits 63

Table 56: Implantable Cardioverter Defibrillators, Pipeline Products, 2011 64

Table 57: Implantable Cardioverter Defibrillators, AnalyST Accel, 2011 65

Table 58: Implantable Cardioverter Defibrillators, AnalyST, 2011 65

Table 59: Implantable Cardioverter Defibrillators CardiaLen, 2011 66

Table 60: Implantable Cardioverter Defibrillators, Chronicle, 2011 66

Table 61: Implantable Cardioverter Defibrillators, Clinical trials of Chronicle ICD 67

Table 62: Implantable Cardioverter Defibrillators, Current Plus, 2011 68

Table 63: Implantable Cardioverter Defibrillators, ENERGEN, 2011 69

Table 64: Implantable Cardioverter Defibrillators, Fortify ICD, 2011 69

Table 65: Implantable Cardioverter Defibrillators, INCEPTA, 2011 70

Table 66: Implantable Cardioverter Defibrillators, Paradym DR, 2011 70

Table 67: Implantable Cardioverter Defibrillators, Paradym VR Model 8250, 2011 71

Table 68: Implantable Cardioverter Defibrillators, PUNCTUA, 2011 71

Table 69: Implantable Cardioverter Defibrillators, S-ICD, 2011 72

Table 70: Implantable Cardioverter Defibrillators, Clinical Trials of S-ICD 72

Table 71: Implantable Cardioverter Defibrillators, Unconditional MRI Compatible ICD, 2011 73

Table 72: Cardiac Resynchronization Therapy-Defibrillators , Pipeline Products, 2011 74

Table 73: Cardiac Resynchronization Therapy-Defibrillators , ENERGEN, 2011 75

Table 74: Cardiac Resynchronization Therapy-Defibrillators, INCEPTA, 2011 75

Table 75: Cardiac Resynchronization Therapy-Defibrillators, Quad Polar, 2011 76

Table 76: Cardiac Resynchronization Therapy-Defibrillators, Paradym RF 8770 SonR, 2011 76

Table 77: Cardioverter Resynchronization Therapy-Defibrillators, Clinical Trials of Paradym RF 8770 SonR 77

Table 78: Cardiac Resynchronization Therapy-Defibrillators, Paradym RF Platform, 2011 77

Table 79: Cardiac Resynchronization Therapy-Defibrillators, Platinium ICD-CRT-D, 2011 78

Table 80: Cardiac Resynchronization Therapy-Defibrillators, Promote Quadra, 2011 78

Table 81: Cardiac Resynchronization Therapy-Defibrillators, Clinical Trials of Promote Quadra 79

Table 82: Cardiac Resynchronization Therapy-Defibrillators, PUNCTUA, 2011 80

Table 83: Cardiac Resynchronization Therapy-Defibrillators, Unify Quadra, 2011 80

Table 84: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillator Market, Deals Landscape 81

List of Figures

Figure 1: Types of Arrhythmia 12

Figure 2: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy- Defibrillators Market, Global, Revenue ($bn), 2003-2010 15

Figure 3: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), 2010-2017 16

Figure 4: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2003-2010 24

Figure 5: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2010-2017 25

Figure 6: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Canada, Revenue ($m), 2003-2010 26

Figure 7: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), 2010-2017 27

Figure 8: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2003-2010 28

Figure 9: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2010-2017 29

Figure 10: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2003-2010 30

Figure 11: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2010-2017 31

Figure 12: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2003-2010 32

Figure 13: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2010-2017 33

Figure 14: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2003-2010 34

Figure 15: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2010-2017 35

Figure 16: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2003-2010 36

Figure 17: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2010-2017 37

Figure 18: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2003-2010 38

Figure 19: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2010-2017 39

Figure 20: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2003-2010 40

Figure 21: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2010-2017 41

Figure 22: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2003-2010 42

Figure 23: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2010-2017 43

Figure 24: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2003-2010 44

Figure 25: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2010-2017 45

Figure 26: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Brazil, Revenue ($m), 2003-2010 46

Figure 27: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), 2010-2017 47

Figure 28: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Company Share (%), 2010 48

Figure 29: Implantable Cardioverter Defibrillators, Pipeline Products by Development Stage, 2011 64

Figure 30: Cardiac Resynchronization Therapy-Defibrillators, Pipeline Products by Developmental Stage, 2011 74

Companies Mentioned

Medtronic, Inc

St Jude Medical, Inc

Boston Scientific Corporation

Biotronik

Sorin Group

To order this report:

Cardiovascular Devices Industry: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Cardiovascular Devices Business News

More  Industry Analysis and Insights

CONTACT:

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
2. Can Implantable Devices for Heart Failure Help Assess Risk of Future Adverse Events for Heart Failure Patients?
3. Implantable Defibrillators Lower Risk of Death in Older Heart Patients
4. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
5. New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
6. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
7. AHRQ and American College of Cardiology Collaborate On Study of Implantable Cardioverter Defibrillators
8. FDA Advisory Panel Votes 15 to 0 in Favor of Approving Envoy Medicals Esteem(R) Fully Implantable Hearing Restoration System
9. Access MediQuip Announces Release of the Countrys First Centralized Recall Management Service(SM) for Implantable Devices
10. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
11. Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):